Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Feb
12
2024
Israel Grants the World’s First Regulatory Approval for Cultivated Beef Keller and Heckman LLP
Feb
9
2024
McDermottPlus Check-Up: February 9, 2024 McDermott Will & Emery
Feb
9
2024
Finalizing PFAS Detection Methods, EPA Moves Closer to Locating and Limiting Further PFAS Releases and Requiring Their Cleanup Hunton Andrews Kurth
Feb
9
2024
ECHA’s New Database for Chemicals Includes Information from all REACH Registrations Bergeson & Campbell, P.C.
Feb
9
2024
Three Individuals Sentenced for $3.5 Million COVID-19 Relief Fraud Scheme ArentFox Schiff LLP
Feb
9
2024
Congressional Delegation Comments on Pending Petition Regarding “Free Range” and “Pasture-Raised” Claims Keller and Heckman LLP
Feb
9
2024
This Week in 340B: January 31 – February 7, 2024 McDermott Will & Emery
Feb
8
2024
Rules of Evidence Require Weighing Relevance of Evidence Against Potential Prejudice McDermott Will & Emery
Feb
8
2024
Fraud May Not Always Unravel All–What Does the Contract Say? K&L Gates
Feb
7
2024
Opioid Treatment Programs: SAMHSA Makes Permanent Regulatory Flexibilities Foley & Lardner LLP
Feb
7
2024
FDA Announces Update to Fruit Pouch Contamination Investigation Keller and Heckman LLP
Feb
7
2024
NJ Approves Cannabis Regulatory Amendment with Major Impacts on Class 5 Retail License Holders Epstein Becker & Green, P.C.
Feb
7
2024
Regulatory Compliance Is Now More Accessible for the Cannabis and Hemp Insurance Market Wilson Elser Moskowitz Edelman & Dicker LLP
Feb
6
2024
New California Bills Would Require Naloxone in the Workplace to Respond to Drug Overdoses Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Feb
6
2024
5 Trends to Watch: 2024 Class Actions Greenberg Traurig, LLP
Feb
6
2024
New SAMHSA Rule Expands Access to Medications for the Treatment of Opioid Use Disorder Polsinelli PC
Feb
6
2024
China Solicits Comments on Food Labeling Standard Keller and Heckman LLP
Feb
6
2024
Florida Governor Supports Lab-Grown (Cultivated) Meat Ban Keller and Heckman LLP
Feb
6
2024
Unpacking Averages: Device Manufacturers Should Use the Newly Released Demographic Data in MDRs to Ensure Their Devices Are Not Disproportionately Hurting Minorities Epstein Becker & Green, P.C.
Feb
6
2024
FDA’s Office of Prescription Drug Promotion Issues Its First Untitled Letter of the Year to Novartis for Misleading Statement Relating to KISQALI® Sheppard, Mullin, Richter & Hampton LLP
Feb
5
2024
Cannabis Rescheduling: HHS Findings and Legal Implications Sheppard, Mullin, Richter & Hampton LLP
Feb
5
2024
Don’t Assume Nonalcoholic Beverage Ingredients Are OK for Alcoholic Beverages McDermott Will & Emery
Feb
5
2024
Healthcare Preview for the Week of: February 5, 2024 [PODCAST] McDermott Will & Emery
Feb
5
2024
EPA Formally Reinstates All Chlorpyrifos Tolerances but Signals It Will Revoke Most of Them in the Future Beveridge & Diamond PC
Feb
5
2024
Court Finds Red Cross Has Antitrust Immunity, Rejecting Broad Interpretation of the Sherman Act McDermott Will & Emery
Feb
5
2024
2023 Retail Industry Year in Review Hunton Andrews Kurth
Feb
2
2024
McDermottPlus Check-Up: February 2, 2024 McDermott Will & Emery
Feb
1
2024
EuropaBio Publishes Biomanufacturing Global Series Reports on the United States, India, and Japan Bergeson & Campbell, P.C.
Feb
1
2024
Illinois to Ban Certain Food Additives, Following California, New York, and New Jersey Keller and Heckman LLP
Feb
1
2024
Bringing A New Healthy Food Ingredient to Market: Understanding the Regulatory Pathways Foley & Lardner LLP
Jan
31
2024
FDA Revises Draft HARPC Guidance Keller and Heckman LLP
Jan
31
2024
OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trial Sheppard, Mullin, Richter & Hampton LLP
Jan
30
2024
Blue Diamond “Smokehouse” Almonds Challenged Keller and Heckman LLP
Jan
30
2024
China’s Supreme People’s Court Upholds 79 Million RMB Win for Château Lafite Rothschild in Wine Trademark Case Schwegman, Lundberg & Woessner, P.A.
Jan
29
2024
Gold Dome Report – Legislative Day 10 (2024) Nelson Mullins
Jan
29
2024
2024 Top-of-Mind Issues for Life Sciences Companies Sheppard, Mullin, Richter & Hampton LLP
Jan
26
2024
FDA Takes First Step Toward International Regulation of Gene Therapies to Treat Rare Diseases Greenberg Traurig, LLP
Jan
25
2024
FDA Lists Regulations Under Development and Updates Priority Guidance Topics for Foods Program Keller and Heckman LLP
Jan
25
2024
An Overview of the US Food and Drug Administration's Legislative Goals (Part I) K&L Gates
Jan
25
2024
A New Era For New Jersey’s Liquor Law: Comprehensive Reforms Enacted Norris McLaughlin P.A.
Jan
24
2024
CY 2024 OPPS Final Rule Summary for RI Year-End Review Polsinelli PC
Jan
24
2024
“No Preservatives” Claim Challenged Keller and Heckman LLP
Jan
24
2024
High Expectations: New Jersey’s Rocky Road to Cannabis Consumption Lounges Norris McLaughlin P.A.
Jan
23
2024
Select Highlights from CY 24 Medicare Physician Fee Schedule Final Rule Polsinelli PC
Jan
23
2024
Trending in Telehealth: January 4 – 15, 2024 McDermott Will & Emery
Jan
23
2024
Fiji Water Maker Sued Over Microplastics Keller and Heckman LLP
Jan
23
2024
Florida PBM Law Limits Mail-Order Prescription Drug Programs, Requires State Filings by Employer Plans Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
22
2024
Gold Dome Report – Legislative Day 6 (2024) Nelson Mullins
Jan
22
2024
Federal Judge Rejects Pharma Manufacturers’ Challenge to Negative OIG Advisory Opinion Mintz
Jan
22
2024
Tips for Alcohol Suppliers Utilizing Social Media McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins